Home Cart Sign in  
Chemical Structure| 1612888-66-0 Chemical Structure| 1612888-66-0

Structure of Alofanib
CAS No.: 1612888-66-0

Chemical Structure| 1612888-66-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Alofanib is a selective and allosteric inhibitor of FGFR2 with potential antitumor activity.

Synonyms: RPT835

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Alofanib

CAS No. :1612888-66-0
Formula : C19H15N3O6S
M.W : 413.40
SMILES Code : O=C(O)C1=CC=CC(S(=O)(NC2=CC(C3=CC=CN=C3)=C(C)C=C2[N+]([O-])=O)=O)=C1
Synonyms :
RPT835
MDL No. :MFCD30747921
InChI Key :QUQGQIASFYWKAB-UHFFFAOYSA-N
Pubchem ID :86280646

Safety of Alofanib

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Alofanib

RTK

Isoform Comparison

Biological Activity

Target
  • FGFR2

In Vitro:

Cell Line
Concentration Treated Time Description References
HAMSCs 1-5 µM 3 hours To inhibit FGFR2 function and evaluate its effect on angiogenic capacity. Results showed that alofanib did not significantly affect the angiogenic ability of GDM-hAMSCs. PMC8691045

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT04071184 Gastric Cancer PHASE1 UNKNOWN 2020-12-01 N.N.Blokhin Russian Cancer Res... More >>earch Centre, Dept. of Clinical Pharmacology and Chemotherapy, Moscow, 115478, Russian Federation|Omsk Regional Cancer Center, Omsk, Russian Federation|Rostov Research Institute of Oncology, Rostov-on-Don, Russian Federation|St. Petersburg City Cancer Center, Saint Petersburg, Russian Federation Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.42mL

0.48mL

0.24mL

12.09mL

2.42mL

1.21mL

24.19mL

4.84mL

2.42mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories